Table 3. Results of the analysis of MCM6 expression in relation to the overall survival time in 70 patients with MCL.
| MCM6 expression | n (%) | Median OS (months) | 5-year survival (%) | P-value |
|---|---|---|---|---|
| Quartile 1 12.0–44.7% | 18 (25.7) | 40.0 | 22.2 | <0.0001 |
| Quartile 2 49.0–65.4% | 18 (25.7) | 36.0 | 11.1 | |
| Quartile 3 65.8–77.8% | 17 (24.3) | 25.4 | 0 | |
| Quartile 4 79.2–95.6% | 17 (24.3) | 17.5 | 0 | |
| 0–25% | 5 (7.1) | Not reached | 60.0 | <0.0001 |
| >25–50% | 14 (20.0) | 38.2 | 14.3 | |
| >50–75% | 32 (45.7) | 30.0 | 6.3 | |
| >75–100% | 19 (27.1) | 16.0 | 0 | |
OS=overall survival time.